The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Dr. Stephen Mack and colleagues have developed a framework for discovering targets in ependymomas, and other cancer that lack known genetic drivers, thereby also providing insights into treatment strategies.
Researchers have now discovered a mechanism by which cells can regulate switching between the two proteins, opening options for the development of novel therapeutic strategies to control cancer growth in the future.
Dr. Trey Westbrook has been named the newest McNair Scholar. This recognition will support his work focused on discovering the genes and mechanisms that drive breast cancer and developing the next generation of cancer medicines.
An effort between a surgical oncologist and plastic surgeon can provide an opportunity for women diagnosed with breast cancer to not only have the lump removed, but also get a breast lift at the same time.
Oct. 13 has been declared Metastatic Breast Cancer Day by the Senate of the State of Texas. In honor of this proclamation, Baylor College of Medicine is launching a new program aimed at fighting the disease.
Researchers have completed a comprehensive molecular characterization of 412 muscle-invasive bladder cancers that resulted in the identification of five cancer subtypes with different susceptibilities to specific therapies.
Baylor College of Medicine has received a Rally for Research Grant from the Rally Foundation for Childhood Cancer Research to support Dr. Tsz-Kwong (Chris) Man and his research in targeting methylome in chemo-resistant osteosarcoma.